{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:38:52Z","timestamp":1792471132269,"version":"4.5.0"},"reference-count":38,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To evaluate the real\u2010world effectiveness, safety, and tolerability of the Omnipod 5 hybrid closed\u2010loop system in adults with type 1 diabetes (T1D) with a novel focus on cardiometabolic markers alongside diabetic eye disease and renal function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A single\u2010centre, retrospective analysis of adults with T1D using Omnipod 5 was conducted. Case notes were reviewed for routinely collected clinical data. Continuous glucose monitoring (CGM) metrics were obtained from cloud\u2010based platforms at 3, 6 and 12\u2009months. Paired data were analysed with two\u2010tailed\n                      <jats:italic>t<\/jats:italic>\n                      \u2010tests or Wilcoxon signed\u2010rank, with results presented as mean (SD) or median (IQR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One hundred individuals were included (63% female). At baseline, median age was 28 (23.0\u201337.8) years, BMI 27.0 (22.3\u201330.0) kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , diabetes duration 16.0 (9.0\u201324.8) years and mean HbA1c 68 (\u00b118.0) mmol\/mol. Over half (52%) transitioned from multiple daily injections. Significant glycaemic improvements were observed by 3\u2009months. Improvements were durable to 12\u2009months, with mean HbA1c falling from 68.5 to 58.8\u2009mmol\/mol (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200975) and time in range (TIR) increasing from 43.4% to 58.3% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200986). The greatest glycaemic improvements were observed in those with lower TIR at baseline. Retinopathy progression occurred in a minority of 10 individuals, all of whom had a baseline HbA1c &gt;\u200953\u2009mmol\/mol.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Initiation of Omnipod 5 was associated with durable glycaemic improvements. Preliminary data generate the hypothesis that retinopathy progression may be concentrated among individuals with baseline HbA1c above target range. Prospective studies are required to evaluate long\u2010term retinal and cardiometabolic outcomes while controlling for concomitant weight and lipid\u2010lowering therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.71129","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:57:35Z","timestamp":1784602655000},"page":"9166-9177","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Looking Beyond Glycaemic Control: Real\u2010World 12\u2010Month Cardiometabolic and Retinopathy Outcomes Following Omnipod 5 Initiation in People With Type 1 Diabetes"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9406-9644","authenticated-orcid":false,"given":"Eleanor","family":"McNally","sequence":"first","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield  Sheffield UK"},{"name":"Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Goodman","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Morris","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Maliekkal","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalha","family":"Saeed","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao Wei","family":"Tan","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield  Sheffield UK"},{"name":"Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9100-8778","authenticated-orcid":false,"given":"Simon","family":"Berry","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield  Sheffield UK"},{"name":"Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Elliott","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Iqbal","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield  Sheffield UK"},{"name":"Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(22)00218\u20102"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21\u20100172"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24\u2010S007"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125\u2010024\u201006308\u2010z"},{"key":"e_1_2_10_6_1","unstructured":"\u201cOverview | Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes | Guidance | NICE \u201d(2023) https:\/\/www.nice.org.uk\/guidance\/ta943."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci19\u20100028"},{"key":"e_1_2_10_8_1","unstructured":"\u201cNational Diabetes Audit 2021\u201322 Type 1 Diabetes \u2013 Overview \u201dNHS England Digital (2026) https:\/\/digital.nhs.uk\/data\u2010and\u2010information\/publications\/statistical\/national\u2010diabetes\u2010audit\u2010type\u20101\u2010diabetes\/nda\u2010type\u20101\u20102021\u201022\u2010overview."},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300\u2010023\u201001394\u20105"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16553"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc22\u20101711"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.027"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.10.1.1"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2025.101703"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251318740"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0528"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2025.0165"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0568"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/15209156251411929"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886\u2010022\u201001799\u2010x"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15629"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15465"},{"key":"e_1_2_10_23_1","unstructured":"\u201cEnglish Indices of Deprivation 2025: Statistical Release \u201dGOV.UK accessed March 10 2026 https:\/\/www.gov.uk\/government\/statistics\/english\u2010indices\u2010of\u2010deprivation\u20102025\/english\u2010indices\u2010of\u2010deprivation\u20102025\u2010statistical\u2010release."},{"key":"e_1_2_10_24_1","unstructured":"\u201cNHS Diabetic Eye Screening Programme: Grading Definitions for Referable Disease \u201dGOV.UK accessed July 5 2026 https:\/\/www.gov.uk\/government\/publications\/diabetic\u2010eye\u2010screening\u2010retinal\u2010image\u2010grading\u2010criteria\/nhs\u2010diabetic\u2010eye\u2010screening\u2010programme\u2010grading\u2010definitions\u2010for\u2010referable\u2010disease\u2010start\u2010date\u2010october\u201001."},{"key":"e_1_2_10_25_1","unstructured":"ONS \u201cEthnic Group England and Wales: Census 2021 \u201dOffice for National Statistics accessed November 28 2025 https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/culturalidentity\/ethnicity\/bulletins\/ethnicgroupenglandandwales\/census2021."},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7367.746"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0364"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15453"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70000"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70137"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0578"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.7.874"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.02.011"},{"key":"e_1_2_10_34_1","doi-asserted-by":"crossref","unstructured":"M.AnsonandU.Alam \u201cHybrid Closed Loop Insulin Pumps and Early Worsening of Diabetic Retinopathy in Type 1 Diabetes \u201dhttps:\/\/doi.org\/10.1186\/ISRCTN11740459.","DOI":"10.1186\/ISRCTN11740459"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02870316"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P060657"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.3.S27"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.11.7.567"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71129","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.71129","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:49:31Z","timestamp":1792468171000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.71129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/dom.71129"],"URL":"https:\/\/doi.org\/10.1111\/dom.71129","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.71129\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71129\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71129\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71129\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71129\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71129\/v1\/review3","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"2026-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}